Skip to main content
Fig. 1 | Molecular Medicine

Fig. 1

From: Platelet-rich plasma inhibits Adriamycin-induced inflammation via blocking the NF-κB pathway in articular chondrocytes

Fig. 1

PRP reduces doxorubicin exposure-increased susceptibility to osteoarthritis. The 12-week-old C57BL/6J mice were under DMM surgery for 1 week and received doxorubicin (10 mg/kg) injection and/or intra-articular injection of 15 μL PRP every week. After 4 weeks, mouse knee joints were collected. A, B Representative images of Safranin O/fast green staining (A) and quantification (B). CE Plasma levels of TNF-α (C), IL-1β (D), and IL6 (E). n = 6. *p < 0.05, vs sham of the same treatment; #p < 0.05, vs control of the same DMM treatment; $p < 0.05, vs doxorubicin of the same DMM treatment

Back to article page